Sahajanand Medical in stents plan

Sahajanand Medical Technologies, a Sahajanand Group subsidiary, has lined up plans to work on several new medical products like special stents for use in angioplasty on heart patients.

Its current range of bare metal stents used in angioplasty has captured about 11 per cent market share in the country, according to a news release issued by the company. It has also entered into a strategic tie-up with Minvysys and Arthesys of Paris.

The company is working on a range of new products including supralimus stents, cobalt-chromium stents, balloon catheters, special stents for diabetic patients and peripheral stents. It is planning to undertake OEM of such stents for other countries.

Sahajanand Medical Technologies' foray in this area has facilitated in a sharp reduction in the price of a bare metal stent from Rs 70,000 four years ago to Rs 35,000 today. The halving of price has been achieved through its indigenisation efforts.

Moreover, it is now come up with the concept of refurbishing cathlabs with the latest technology to reduce capital investment in hospitals and nursing homes.

Sahajanand Group has also been a leader in the laster technology. It has brought laser technology to the Indian diamond industry and increased its market size from Rs 3,000 crore to Rs 60,000 crore in the span of a decade.